Cytostatic drugs differentially affect phenotypic features of porcine coronary artery smooth muscle cell populations

FEBS Lett. 2007 Dec 22;581(30):5847-51. doi: 10.1016/j.febslet.2007.11.060. Epub 2007 Nov 29.

Abstract

We studied the effects of cytostatic drugs on porcine coronary artery spindle-shaped (S) and rhomboid (R) smooth muscle cell (SMC) biological activities related to intimal thickening (IT) formation. Imatinib, and to a lesser extent curcumin, decreased proliferation of S- and R-SMCs and migratory and urokinase activities of R-SMCs more efficiently compared with cyclosporine plus rapamycin. Imatinib increased the expression of alpha-smooth muscle actin in both SMC populations and that of smoothelin in S-SMCs. It decreased S100A4 expression in R-SMCs. By promoting SMC quiescence and differentiation imatinib and curcumin may represent valid candidates for restenosis preventive and therapeutic strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Cell Differentiation / drug effects
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Coronary Vessels / cytology*
  • Coronary Vessels / drug effects*
  • Coronary Vessels / enzymology
  • Cytostatic Agents / pharmacology*
  • Immunoblotting
  • Myocytes, Smooth Muscle / cytology*
  • Myocytes, Smooth Muscle / drug effects*
  • Myocytes, Smooth Muscle / enzymology
  • Phenotype
  • S100 Proteins / metabolism
  • Swine
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Biomarkers
  • Cytostatic Agents
  • S100 Proteins
  • Urokinase-Type Plasminogen Activator